- $171.42m
- $170.16m
- $319.40m
- 86
- 95
- 37
- 84
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 221 | 225 | 238 | 293 | 319 |
Cost of Revenue | |||||
Gross Profit | 61.2 | 61.4 | 60.8 | 83.5 | 92.4 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 208 | 215 | 225 | 263 | 292 |
Operating Profit | 13 | 10.4 | 12.7 | 29.5 | 27.5 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 13 | 11 | 11.7 | 29.1 | 28.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9.43 | 7.79 | 8.39 | 21.3 | 21.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 9.43 | 7.79 | 8.39 | 21.3 | 21.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.36 | 7.72 | 8.31 | 21.2 | 21.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.92 | 1.61 | 1.71 | 4.37 | 4.34 |